Inhalation Asia workshop to cover advanced analytical techniques for in vitro performance testing of orally inhaled and nasal drug products
During the Inhalation Asia 2017 conference, our expert Chris Vernall, Business Development Director, will present a workshop entitled ‘Advanced analytical techniques for the testing of orally inhaled and nasal drug products: How to build confidence in the in-vitro data for your generic product’.
IA17 WORKSHOP: Wednesday, 13 September 2017, 13:00
This workshop will cover:
Contact us to request further information.
Our experts will be at Booth 17 - September 13-15 - to provide updates on the latest developments in our inhaled product development capabilities. Intertek’s integrated formulation and analytical experts undertake early stage pre-formulation support, formulation development, inhalation product analysis and testing, solubility screening, drug-excipient compatibility, stability testing and device selection support to aid clients working to develop formulations targeting specific regions of the respiratory tract or nasal cavity.
Book a meeting request with our team:
Inhalation drug products fall into a range of categories including pressurized metered dose inhalers (pMDI), dry powder inhalers (DPI), nebulizers, nasal sprays and soft mist inhalers. These have different mechanisms of action and therefore different test requirements when determining in vitro product performance. Specialist inhaled drug product testing capabilities and techniques such as laser particle sizing and aerodynamic particle size distribution (APSD) by impaction are necessary to explore the key performance parameters including; Aerodynamic Particle / Droplet Size, Delivered Dose Uniformity, Particle Size or Droplet Size, Spray Pattern / Plume Geometry and Aerodynamic Particle Size Distribution (APSD).
Need help or have a question?